Additionally, the adhesion of multiple myeloma cells to collagen type I via an interaction that involves serglycin CS stimulates these cells to synthesize and secrete matrix metalloproteinase (MMP)‐9 and MMP‐2, which promotes the invasiveness of cancer cells via ECM remodeling 181 (Fig. 3). Here, SRGN is linked to plasma cell myeloma.